Severity of depression and response to antidepressants: GENPOD randomised controlled trial.

Severity of depression and response to antidepressants: GENPOD randomised controlled trial.

BACKGROUND: Antidepressant prescribing is widespread. Nonetheless, response to antidepressants is variable. If it was possible to predict response to medication and thus tailor treatment accordingly, this would not only improve patient outcomes but may also have economic benefits. AIMS: To test the...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Wiles, N, Mulligan, J, Peters, T, Cowen, P, Mason, V, Nutt, D, Sharp, D, Tallon, D, Thomas, L, O'Donovan, M, Lewis, G
Natura:	Journal article
Lingua:	English
Pubblicazione:	2012

Documenti analoghi

GENetic and clinical predictors of treatment response in depression: the GenPod randomised trial protocol.
di: Thomas, L, et al.
Pubblicazione: (2008)

GENetic and clinical Predictors Of treatment response in Depression: the GenPod randomised trial protocol
di: O'Donovan Michael, et al.
Pubblicazione: (2008-05-01)

Allowing for non-adherence to treatment in a randomized controlled trial of two antidepressants (citalopram versus reboxetine): an example from the GENPOD trial.
di: Wiles, N, et al.
Pubblicazione: (2014)

Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trial.
di: Lewis, G, et al.
Pubblicazione: (2011)

Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals.
di: Crawford, A, et al.
Pubblicazione: (2014)

Adverse effects from antidepressant treatment: Randomised controlled trial of 601 depressed individuals
di: Crawford, A, et al.
Pubblicazione: (2014)

A pragmatic randomised controlled trial to compare antidepressants with a community-based psychosocial intervention for the treatment of women with postnatal depression: the RESPOND trial
di: DJ Sharp, et al.
Pubblicazione: (2010-09-01)

Does baseline fatigue influence treatment response to reboxetine or citalopram in depression? An open label randomized controlled trial.
di: Bould, H, et al.
Pubblicazione: (2012)

Does baseline fatigue influence treatment response to reboxetine or citalopram in depression? An open label randomized controlled trial
di: Bould, H, et al.
Pubblicazione: (2012)

Depression resistant to tricyclic antidepressants.
di: Cowen, P
Pubblicazione: (1988)

Serotonin, depression and antidepressant action
di: Cowen, P
Pubblicazione: (2013)

Depression resistant to tricyclic antidepressants.
di: Cowen, P
Pubblicazione: (1988)

Randomised controlled trial of Antiglucocorticoid augmentation (metyrapone) of antiDepressants in Depression (ADD Study)
di: I Nicol Ferrier, et al.
Pubblicazione: (2015-06-01)

A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in dEpRession): study protocol for a randomised controlled trial
di: Larisa Duffy, et al.
Pubblicazione: (2019-06-01)

Antidepressants; what's the beef?
di: Goodwin, G, et al.
Pubblicazione: (2019)

Physical activity as a treatment for depression: the TREAD randomised trial protocol
di: Lawlor Debbie A, et al.
Pubblicazione: (2010-11-01)

A pilot randomised controlled trial of cognitive behavioural therapy for antenatal depression.
di: Burns, A, et al.
Pubblicazione: (2013)

Antidepressant controlled trial for negative symptoms in schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial.
di: Barnes, T, et al.
Pubblicazione: (2016)

Discontinuation of antidepressant medication after mindfulness-based cognitive therapy for recurrent depression: randomised controlled non-inferiority trial.
di: Huijbers, M, et al.
Pubblicazione: (2016)

Antidepressants Trial in Parkinson's Disease (ADepT-PD): protocol for a randomised placebo-controlled trial on the effectiveness of escitalopram and nortriptyline on depressive symptoms in Parkinson’s disease
di: A Schrag, et al.
Pubblicazione: (2022-12-01)

Tyrosine depletion does not cause depressive relapse in antidepressant-treated patients.
di: McTavish, S, et al.
Pubblicazione: (2004)

Attacks on antidepressants: signs of deep-seated stigma?
di: Nutt, D, et al.
Pubblicazione: (2014)

A pragmatic randomised controlled trial to evaluate the cost-effectiveness of a physical activity intervention as a treatment for depression: the treating depression with physical activity (TREAD) trial
di: M Chalder, et al.
Pubblicazione: (2012-03-01)

Neurokinin-1 receptor antagonists as novel antidepressants: trials and tribulations.
di: Hafizi, S, et al.
Pubblicazione: (2007)

The effects of using the PReDicT Test to guide the antidepressant treatment of depressed patients: study protocol for a randomised controlled trial
di: Kingslake, J, et al.
Pubblicazione: (2017)

SSRIs versus other antidepressants for depressive disorder.
di: Geddes, J, et al.
Pubblicazione: (2000)

Systematic review of pindolol augmentation of serotonergic antidepressant treatment for major depressive disorder
di: Whale, R, et al.
Pubblicazione: (2005)

Cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment resistant depression in primary care: the CoBalT randomised controlled trial protocol.
di: Thomas, L, et al.
Pubblicazione: (2012)

Suicide, depression, and antidepressants.
di: Cipriani, A, et al.
Pubblicazione: (2005)

Antidepressants for bipolar depression.
di: Ghaemi, SN, et al.
Pubblicazione: (2005)

Platelet 5-HT receptor binding during depressive illness and tricyclic antidepressant treatment.
di: Cowen, P, et al.
Pubblicazione: (1987)

Antidepressants and reward
di: McCabe, C, et al.
Pubblicazione: (2012)

Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT
di: Larisa Duffy, et al.
Pubblicazione: (2021-11-01)

The effects of using the PReDicT Test to guide the antidepressant treatment of depressed patients: study protocol for a randomised controlled trial
di: Jonathan Kingslake, et al.
Pubblicazione: (2017-11-01)

The PRESIDE (PhaRmacogEnomicS In DEpression) Trial: a double-blind randomised controlled trial of pharmacogenomic-informed prescribing of antidepressants on depression outcomes in patients with major depressive disorder in primary care
di: Sibel Saya, et al.
Pubblicazione: (2023-05-01)

Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial
di: Thomas RE Barnes, et al.
Pubblicazione: (2016-04-01)

Withdrawal of unnecessary antidepressant medication: a randomised controlled trial in primary care
di: Rhona Eveleigh, et al.
Pubblicazione: (2017-11-01)

Integrated therapist and online CBT for depression in primary care (INTERACT): study protocol for a multi-centre randomised controlled trial
di: Debbie Tallon, et al.
Pubblicazione: (2023-06-01)

Antidepressants: current concepts of mode of action.
di: Cowen, P
Pubblicazione: (1990)

Positive anxiety or depression screen despite ongoing antidepressant prescription in people with epilepsy: A large cross-sectional analysis
di: Samantha Ongchuan Martin, et al.
Pubblicazione: (2022-01-01)